NICE must do better at summarising and communicating evidence on statins

BMJ. 2014 Sep 3:349:g5081. doi: 10.1136/bmj.g5081.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cardiovascular Diseases / prevention & control*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Lipids / blood*
  • Risk Assessment*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lipids